Gastrointestinal Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Nina N. Grenon, DNP, AGCNP-BC, AOCN® and Kristen O’Hagan, MSN, ANP-BC, AOCNP®
J Adv Pract Oncol 2022;13(6):586-595 |
© 2022 Harborside™
Nina N. Grenon, DNP, AGCNP-BC, AOCN®, of Dana-Farber Cancer Institute, evaluates data on RAS wild-type metastatic colorectal cancer, locally advanced mismatch repair–deficient rectal cancer, circulating tumor DNA tests, pancreatic neuroendocrine tumors, and nonresectable locally advanced pancreatic cancer. Kristen O’Hagan, MSN, ANP-BC, AOCNP®, of Memorial Sloan Kettering Cancer Center, reviews research on disparities in receiving guideline-concordant care among patients with colorectal cancer.
For access to the full length article, please sign in